Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Role of Telehealth Technologies in the Creation of Smart Hospitals

Telehealth has been around for quite a while. However, it took the pandemic to generate widespread adoption and acceptance of telehealth in hospitals globally. In this episode of “Health and Life Sciences at the Edge,” host Justin Honore talks with Intel’s Ed Buffone about the technologies that are making Smart Hospitals a reality and the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Telehealth has been around for quite a while. However, it took the pandemic to generate widespread adoption and acceptance of telehealth in hospitals globally. In this episode of “Health and Life Sciences at the Edge,” host Justin Honore talks with Intel’s Ed Buffone about the technologies that are making Smart Hospitals a reality and the challenges that must still be addressed.

“During the pandemic, the healthcare system was under siege. This virus was draining the resources of every hospital in the country,” says Buffone. “We needed alternative ways to reach and treat patients. The two technologies that made that possible were virtual visits and remote monitoring.” However, telehealth encompasses a broad range of technologies and applications that must work seamlessly together to make Smart Hospitals viable. “What hospitals lack is an organized, holistic approach to telehealth,” says Buffone. “In many hospitals, individual departments deploy telehealth, but they’re siloed. The solution is a cohesive, enterprise-wide approach.”

The three major technologies driving the move to Smart Hospitals are Artificial Intelligence (AI), Analytics, and 5G. “AI is a key element that makes hospitals Smart Hospitals,” says Buffone. “Healthcare is an industry that is rich in data, and AI takes advantage of that data to give clinicians more insight into patient care.” Buffone refers to AI as Assisted rather than Artificial Intelligence. “When it comes to healthcare, there’s nothing artificial about AI,” he says. “The clinician is making the intelligent decisions for the patient. AI just provides data that can help.”

Working alongside AI are analytics and 5G. Analytics provide insights into patient populations and 5G extends patient care networks, making it possible to follow patients through their care journeys.

According to Buffone, there are three main hurdles to implementing these technologies in hospitals – finances, staffing, and lack of organization. “I think the real solution is maturity,” says Buffone. “Maturity of the technologies and the processes. As these technologies become more accepted and integrated into the workflow, the overall financial lift lessens. At that point everyone has a clear understanding of the return on investment and how the technologies provide for lower costs, most efficiency, and better patient satisfaction. Ultimately, that’s what we’re after,” Buffone adds. “It’s all about the patient journey, patient satisfaction, and patient safety. If you can do that while lowering costs and providing more operational efficiencies those barriers will fall away.”

Connect with Ed Buffone on LinkedIn. 

Follow us on Twitter: @IntelHealth 

To learn more about telehealth and Smart Hospitals visit: https://www.intel.com/content/www/us/en/healthcare-it/smart-hospital.html 

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group. 

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512